8-K filing — Matinas BioPharma Holdings, Inc. (MTNB)
Filed: 2026-11-03 AccNo: 0001493152-26-049802 Size: 199 KB Item 8.01: Other Events
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-11-03 AccNo: 0001493152-26-049802 Size: 199 KB Item 8.01: Other Events
On June 23, 2025, at the 2025 annual meeting of stockholders of Matinas BioPharma Holdings, Inc. (the "Company"), the stockholders approved the authorization of the Board of Directors (the "Board"), in
Matinas BioPharma received a notice from NYSE American on August 31, 2026, stating the company is not in compliance with continued listing standards due to stockholders' equity of $1.8 million (below the required $2.0 million threshold) and losses in five consecutive fiscal years. The company submitted a compliance plan accepted by NYSE American with a deadline of October 2, 2027. Shares will continue trading during the plan period, but delisting proceedings may be initiated if compliance is not achieved.
Gainers Circle8 Group (NASDAQ:CIRC) shares increased by 18.2% to $0.77 during Thursday's pre-market session. The company's market cap stands at $60.1 million. The company's, Q2 earnings came out yesterday.
Webull Corp (NASDAQ: BULL) rose sharply in pre-market trading after reporting better-than-expected Q2 results. Revenue of $198.83M beat estimates, while adjusted EPS of $0.05 also beat.